Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/AVALO-THERAPEUTICS-INC-23733730/attualita/Avalo-Therapeutics-Inc-annuncia-la-somministrazione-del-primo-paziente-nello-studio-di-Fase-2-PEAK-40475160/?utm_source=whatsapp&utm_medium=social&utm_campaign=share